160 related articles for article (PubMed ID: 25022254)
1. Impact of comorbidity on survival after palliative radiotherapy.
Nieder C; Engljähringer K; Angelo K
Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
[TBL] [Abstract][Full Text] [Related]
2. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
3. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of the oldest old-feasibility and institutional analysis.
Kretschmer EM; Pavic M; Stark LS; Hertler C; Guckenberger M
Strahlenther Onkol; 2020 Aug; 196(8):683-690. PubMed ID: 32367454
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
Nieder C; Kämpe TA
Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
7. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale".
Kos FT; Yazici O; Civelek B; Seker M; Arik Z; Aksoy S; Uncu D; Ozdemir N; Zengin N
Wien Klin Wochenschr; 2014 Jan; 126(1-2):36-41. PubMed ID: 24249323
[TBL] [Abstract][Full Text] [Related]
9. Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time.
Yamaguchi S; Ohguri T; Matsuki Y; Yahara K; Narisada H; Imada H; Korogi Y
Radiat Oncol; 2013 Jul; 8():166. PubMed ID: 23829540
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients.
Rief H; Muley T; Bruckner T; Welzel T; Rieken S; Bischof M; Lindel K; Combs SE; Debus J
Strahlenther Onkol; 2014 Jan; 190(1):59-63. PubMed ID: 24052009
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
[TBL] [Abstract][Full Text] [Related]
12. Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
Tseng YD; Gouwens NW; Lo SS; Halasz LM; Spady P; Mezheritsky I; Loggers E
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):21-29. PubMed ID: 29487025
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy in Older Patients ≥70 Years Receiving Palliative Radiotherapy.
Nieder C; Mannsăker B; Pawinski A; Haukland E
Anticancer Res; 2017 Feb; 37(2):795-799. PubMed ID: 28179332
[TBL] [Abstract][Full Text] [Related]
14. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
15. Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs.
Gerdan L; Segedin B; Nagy V; Khoa MT; Trang NT; Schild SE; Rades D
Strahlenther Onkol; 2014 Jan; 190(1):64-7. PubMed ID: 24104871
[TBL] [Abstract][Full Text] [Related]
16. Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study.
Inoue HK; Sato H; Suzuki Y; Saitoh J; Noda SE; Seto K; Torikai K; Sakurai H; Nakano T
Radiat Oncol; 2014 Oct; 9():231. PubMed ID: 25322826
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and Characteristics of Patients Treated with Emergent Palliative Radiation Therapy.
Grade M; Koenig J; Qian Y; Sandhu N; Liu Y; Turner B; von Eyben R; Knox S; Dudley S
Pract Radiat Oncol; 2019 Mar; 9(2):e203-e209. PubMed ID: 30529795
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.
van Oorschot B; Assenbrunner B; Schuler M; Beckmann G; Flentje M
Strahlenther Onkol; 2014 Mar; 190(3):270-5. PubMed ID: 24413894
[TBL] [Abstract][Full Text] [Related]
19. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
20. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Stevens R; Macbeth F; Toy E; Coles B; Lester JF
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
